These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1000921)

  • 21. [Effects of LBI45, practolol and a placebo on the exercise tests of coronary patients. A double-blind study (author's transl)].
    Bloch A; Horvat L
    Schweiz Rundsch Med Prax; 1974 Jan; 63(3):62-5. PubMed ID: 4605646
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of oral pentaerythritol tetranitrate in cardiac failure and angina pectoris. Assessment by hemodynamic measurement and exercise capacity.
    Amsterdam EA; Lee G; Awan NA; Low R; Mason DT
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2443-6. PubMed ID: 7422533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The pharmacodynamics of proxodolol when administered once and in a course of doses to patients with stenocardia of effort].
    Petrov IN; Rumiantsev AS; Smirnov MV
    Eksp Klin Farmakol; 1994; 57(3):54-7. PubMed ID: 7914123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pindolol: exercise testing and angina.
    Jennings G; Bobik A; Korner PI
    Med J Aust; 1977 Sep; 2(SP2):6-7. PubMed ID: 927283
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effect of a single administration of diltiazem on exercise tolerance in patients with stable angina pectoris].
    Meluzín J; Lupínek Z; Rysavý F
    Vnitr Lek; 1988 Oct; 34(10):942-9. PubMed ID: 3212946
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of nicorandil on exercise performance in patients with effort angina: a multicenter trial using a treadmill exercise test.
    Kato K; Asanoi H; Wakabayashi C; Hosoda S; Shiina A; Hosono K; Kurita A; Seki K; Ishida K; Kuroiwa A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S98-103. PubMed ID: 2447432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anti-ischemic action of the transdermally applied beta-receptor blocker, mepindolol in patients with stable angina pectoris].
    Bonelli J; Gazo F; Liedtke RK
    Arzneimittelforschung; 1989 Nov; 39(11A):1515-7. PubMed ID: 2576203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cardiac function during exercise in effort angina. Part 1. A comparative study of dynamic exercise and static exercise (author's transl)].
    Itoh K
    Nihon Naika Gakkai Zasshi; 1981 Oct; 70(10):1388-400. PubMed ID: 7328358
    [No Abstract]   [Full Text] [Related]  

  • 29. [Complex spiroergometric evaluation of the results of 1 month physical training of patients with angina pectoris].
    Dvorák I; Zemánková J; Steifa M
    Vnitr Lek; 1975 Feb; 21(2):118-23. PubMed ID: 1114716
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of isometric exertion (handgrip) on left-ventricular activity in angina pectoris evaluated by ultrasonocardiography].
    Trojnar R; Rymar B; Markiewicz M
    Kardiol Pol; 1981; 24(6):439-44. PubMed ID: 7265615
    [No Abstract]   [Full Text] [Related]  

  • 31. Prindolol (Visken) and alprenolol (Aptin) in angina pectoris: a comparative clinical study with special reference to ergometer working capacity tests.
    Bjerle P; Jacobsson KA
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):101-16. PubMed ID: 4218804
    [No Abstract]   [Full Text] [Related]  

  • 32. [The acute and chronic effects of 50 mg of isosorbide 5-mononitrate with delayed action in patients with stable angina of effort].
    San José Garagarza J; Ruano Calvo J; Vázquez de Prada JA; Colman Dejean T; López Somoza C; Pajarón López A
    Rev Esp Cardiol; 1992 Feb; 45(2):103-10. PubMed ID: 1561466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitroderm TTS in exercise-induced angina pectoris--a randomized double-blind study.
    Colombo G; Favini G; Aglieri S; Pollavini G; de Vita C
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):211-4. PubMed ID: 3922903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinicopharmacological studies with pindolol following intravenous and oral administration].
    Aellig WH
    Adv Clin Pharmacol; 1976; 11():9-13. PubMed ID: 1032575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of atenolol on treadmill performance in patients with angina pectoris.
    Kritzer G; Warr TA; Strong ML; Froelicher VF
    Clin Pharm; 1983; 2(3):236-42. PubMed ID: 6349909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of single dose administration of a new beta-blockader (pindolol) prior to onset of angina pectoris as evaluated by exercise tests on a bicycle ergometer].
    Vajola SF; Romei E; Lax A; Jacovella G
    Clin Ter; 1980 Feb; 92(3):257-67. PubMed ID: 7449312
    [No Abstract]   [Full Text] [Related]  

  • 37. [Perhexiline maleate in angina pectoris. Study of tolerance to treadmill exercise].
    Souza AD
    Arq Bras Cardiol; 1973 Aug; 26 Suppl 1():83-8. PubMed ID: 4595480
    [No Abstract]   [Full Text] [Related]  

  • 38. [Exercise tolerance in patients with exertion angina pectoris after therapeutic plasmapheresis].
    Sharandak AP; Postnikov AA; Model SV; Timakov AV; Mikhaĭlov AV
    Kardiologiia; 1990 Aug; 30(8):58-60. PubMed ID: 2255146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of nifedipine on exercise tolerance in angina pectoris.
    McIlwraith GR; Kidner PH; Oram S
    Br Heart J; 1980 Sep; 44(3):335-41. PubMed ID: 7426191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac dose-response relationships of oral and intravenous pindolol.
    Carruthers SG
    Br J Clin Pharmacol; 1982; 13(Suppl 2):193S-198S. PubMed ID: 7104142
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.